N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine

C138H142F20N44 — CID 158539276

IUPACN-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine
SMILESCN(c1ncc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(c1ncc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)c3ncc(F)cc3C(F)(F)F)CC2)c1C.Cc1cnncc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cn1nccc1-c1nnc(N2CCC(Nc3ncc(F)cc3C(F)(F)F)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ncc(F)cc3C(F)(F)F)CC2)c2cnccc12
InChIInChI=1S/C24H23F4N7.C24H28N8.C23H25F4N7.C23H21F4N7.C22H20F4N8.C22H25F4N7/c1-33(23-19(24(26,27)28)13-15(25)14-29-23)16-8-11-35(12-9-16)22-18-6-4-3-5-17(18)21(31-32-22)20-7-10-30-34(20)2;1-17-14-25-26-15-18(17)16-30(2)19-9-12-32(13-10-19)24-21-7-5-4-6-20(21)23(28-29-24)22-8-11-27-31(22)3;1-32(22-18(23(25,26)27)12-14(24)13-28-22)15-7-10-34(11-8-15)21-17-5-3-4-16(17)20(30-31-21)19-6-9-29-33(19)2;1-33-19(6-9-29-33)20-16-4-2-3-5-17(16)22(32-31-20)34-10-7-15(8-11-34)30-21-18(23(25,26)27)12-14(24)13-28-21;1-33-18(3-7-29-33)19-15-2-6-27-12-16(15)21(32-31-19)34-8-4-14(5-9-34)30-20-17(22(24,25)26)10-13(23)11-28-20;1-13-14(2)20(30-29-19(13)18-5-8-28-32(18)4)33-9-6-16(7-10-33)31(3)21-17(22(24,25)26)11-15(23)12-27-21/h3-7,10,13-14,16H,8-9,11-12H2,1-2H3;4-8,11,14-15,19H,9-10,12-13,16H2,1-3H3;6,9,12-13,15H,3-5,7-8,10-11H2,1-2H3;2-6,9,12-13,15H,7-8,10-11H2,1H3,(H,28,30);2-3,6-7,10-12,14H,4-5,8-9H2,1H3,(H,28,30);5,8,11-12,16H,6-7,9-10H2,1-4H3
InChIKeyHOHYSZWYMWBXIR-UHFFFAOYSA-N
MW2796.92 g/mol
LogP24.82
Rot. Bonds25

About N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine

N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine (PubChem CID 158539276) has the molecular formula C138H142F20N44 and a molecular weight of 2796.92 g/mol. Its IUPAC name is N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine.

Molecular Properties

Compound NameN-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine
PubChem CID158539276
Molecular FormulaC138H142F20N44
Molecular Weight2796.92 g/mol
Exact Mass2795.21
IUPAC NameN-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine
SMILESCN(c1ncc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(c1ncc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)c3ncc(F)cc3C(F)(F)F)CC2)c1C.Cc1cnncc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cn1nccc1-c1nnc(N2CCC(Nc3ncc(F)cc3C(F)(F)F)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ncc(F)cc3C(F)(F)F)CC2)c2cnccc12
InChIInChI=1S/C24H23F4N7.C24H28N8.C23H25F4N7.C23H21F4N7.C22H20F4N8.C22H25F4N7/c1-33(23-19(24(26,27)28)13-15(25)14-29-23)16-8-11-35(12-9-16)22-18-6-4-3-5-17(18)21(31-32-22)20-7-10-30-34(20)2;1-17-14-25-26-15-18(17)16-30(2)19-9-12-32(13-10-19)24-21-7-5-4-6-20(21)23(28-29-24)22-8-11-27-31(22)3;1-32(22-18(23(25,26)27)12-14(24)13-28-22)15-7-10-34(11-8-15)21-17-5-3-4-16(17)20(30-31-21)19-6-9-29-33(19)2;1-33-19(6-9-29-33)20-16-4-2-3-5-17(16)22(32-31-20)34-10-7-15(8-11-34)30-21-18(23(25,26)27)12-14(24)13-28-21;1-33-18(3-7-29-33)19-15-2-6-27-12-16(15)21(32-31-19)34-8-4-14(5-9-34)30-20-17(22(24,25)26)10-13(23)11-28-20;1-13-14(2)20(30-29-19(13)18-5-8-28-32(18)4)33-9-6-16(7-10-33)31(3)21-17(22(24,25)26)11-15(23)12-27-21/h3-7,10,13-14,16H,8-9,11-12H2,1-2H3;4-8,11,14-15,19H,9-10,12-13,16H2,1-3H3;6,9,12-13,15H,3-5,7-8,10-11H2,1-2H3;2-6,9,12-13,15H,7-8,10-11H2,1H3,(H,28,30);2-3,6-7,10-12,14H,4-5,8-9H2,1H3,(H,28,30);5,8,11-12,16H,6-7,9-10H2,1-4H3
InChIKeyHOHYSZWYMWBXIR-UHFFFAOYSA-N
XLogP24.82
TPSA421.18 Ų
H-Bond Donors2
H-Bond Acceptors44
Rotatable Bonds25
Heavy Atoms202
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002796.92
LogP ≤ 524.82
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1044

Analyze N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine?
The IUPAC name of N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine (CID 158539276) is N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine.
What is the SMILES notation for N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine?
The canonical SMILES for N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine is CN(c1ncc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(c1ncc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)c3ncc(F)cc3C(F)(F)F)CC2)c1C.Cc1cnncc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cn1nccc1-c1nnc(N2CCC(Nc3ncc(F)cc3C(F)(F)F)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ncc(F)cc3C(F)(F)F)CC2)c2cnccc12.
What is the InChIKey of N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine?
The InChIKey is HOHYSZWYMWBXIR-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23F4N7.C24H28N8.C23H25F4N7.C23H21F4N7.C22H20F4N8.C22H25F4N7/c1-33(23-19(24(26,27)28)13-15(25)14-29-23)16-8-11-35(12-9-16)22-18-6-4-3-5-17(18)21(31-32-22)20-7-10-30-34(20)2;1-17-14-25-26-15-18(17)16-30(2)19-9-12-32(13-10-19)24-21-7-5-4-6-20(21)23(28-29-24)22-8-11-27-31(22)3;1-32(22-18(23(25,26)27)12-14(24)13-28-22)15-7-10-34(11-8-15)21-17-5-3-4-16(17)20(30-31-21)19-6-9-29-33(19)2;1-33-19(6-9-29-33)20-16-4-2-3-5-17(16)22(32-31-20)34-10-7-15(8-11-34)30-21-18(23(25,26)27)12-14(24)13-28-21;1-33-18(3-7-29-33)19-15-2-6-27-12-16(15)21(32-31-19)34-8-4-14(5-9-34)30-20-17(22(24,25)26)10-13(23)11-28-20;1-13-14(2)20(30-29-19(13)18-5-8-28-32(18)4)33-9-6-16(7-10-33)31(3)21-17(22(24,25)26)11-15(23)12-27-21/h3-7,10,13-14,16H,8-9,11-12H2,1-2H3;4-8,11,14-15,19H,9-10,12-13,16H2,1-3H3;6,9,12-13,15H,3-5,7-8,10-11H2,1-2H3;2-6,9,12-13,15H,7-8,10-11H2,1H3,(H,28,30);2-3,6-7,10-12,14H,4-5,8-9H2,1H3,(H,28,30);5,8,11-12,16H,6-7,9-10H2,1-4H3.
What are the key properties of N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine?
N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine has a molecular weight of 2796.92 g/mol, XLogP of 24.82, 25 rotatable bonds, 2 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-5-fluoro-N-methyl-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;5-fluoro-N-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[(5-methylpyridazin-4-yl)methyl]piperidin-4-amine is sourced from PubChem (CID 158539276), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).